BIOGEN PHARMACHEM INDUSTRIES has announced a book closure period scheduled for late September, preceding its Annual General Meeting.

This crucial step allows the company to finalize the list of shareholders who are eligible to participate and cast their votes at the upcoming AGM.

Shareholders will also have the opportunity to utilize e-voting facilities during a designated window leading up to the meeting, ensuring their voices are heard on key company matters.